Form D · Biotechnology

MicroPhage Inc

Longmont, CO · CIK 0001528424

Offering snapshot reported Oct 19, 2011 · SEC filing

Reported sold
$6M
Offering amount: $12M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 7, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 19, 2011Initial$6,000,000No comparison1SEC filing
Sep 30, 2011Initial$8,514,449No comparison91SEC filing
Sep 30, 2011Initial$6,446,543No comparison90SEC filing
Sep 30, 2011Initial$3,113,715No comparison45SEC filing
Sep 29, 2011Initial$3,705,443No comparison45SEC filing
Sep 29, 2011Initial$1,535,452No comparison26SEC filing
Sep 29, 2011Initial$2,300,962No comparison47SEC filing
Sep 29, 2011Initial$2,511,855No comparison51SEC filing
Sep 29, 2011Initial$1,019,190No comparison29SEC filing

Offering details

Securities
Equity, Debt, Option to acquire
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-167545

Source: Form D, filed Oct 19, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Larry Gold Director
R. Gary Mesch Director
Donald Mooney Director, Executive
Rick Norling Director
Mel Schatz Director
Mark Schwartz Director
Lynn Taussig Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2400 Trade Centre Avenue
Longmont, CO, 80503